Orange County Urology Associates Pioneers Vanquish Water Vapor Ablation for Prostate Care in California

Orange County Urology Associates Pioneers Advanced Prostate Treatment

In a remarkable development for prostate healthcare, Orange County Urology Associates (OCUA) has become the leading provider in California to incorporate the Vanquish® Water Vapor Ablation technology into its routine practice. Dr. Daniel Su, a urologist at OCUA, successfully performed the first commercial procedures utilizing this innovative method, marking a significant step forward in minimally invasive prostate treatments.

The Vanquish system represents a leap in prostate care, using thermal energy from sterile water vapor to precisely ablate targeted prostate tissue via a transurethral approach. This technique is guided by ultrasound and electromagnetic navigation, ensuring that the treatment adheres closely to the prostate's natural contours. This precision is vital as it helps to minimize any adverse effects on nearby nerve bundles that are crucial for maintaining urinary and sexual functions.

The adoption of this technology comes on the heels of promising clinical findings. Initial results from the VAPOR 2 study, published in the Journal of Urology, involved 235 patients with intermediate-risk localized prostate cancer across 26 clinical sites in the U.S. Data showed that 91% of the first 110 patients achieved elimination of targeted MRI-visible disease within six months post-procedure, showcasing the effectiveness of the Vanquish technology without any reported serious adverse events.

The VAPOR 2 pivotal trial also highlighted the procedure's tolerability, showing minimal rates of urinary incontinence and erectile dysfunction among patients. Impressively, after one year, 93% of patients expressed high satisfaction with their outcomes, with 94% agreeing they made a prudent decision to undergo treatment. These outcomes emphasize not just clinical efficacy but also the quality of life improvements that this innovative therapy offers.

Dr. Su shared insights on the integration of the Vanquish system into his practice, noting, "The transition into utilizing Vanquish for our patients has been incredibly smooth. The learning curve is quite manageable for those already familiar with transurethral methods, and the onboarding support was outstanding. We're now able to offer our patients a reliable, effective outpatient prostate treatment option, filling a crucial gap in our services."

Mike Kujak, President and CEO of Francis Medical, echoed Dr. Su's sentiments, stating, "The adoption of Vanquish Water Vapor Ablation is a testament to our aim of creating effective yet practical solutions for urologists. It is essential that physicians can easily incorporate new technologies into their clinical practices. Dr. Su's experiences affirm that Vanquish fulfills this need."

OCUA, located in the heart of Foothill Ranch, California, provides comprehensive urological care, aiming to address a wide variety of urological conditions. With numerous locations across Orange County, the institute is swiftly becoming a cornerstone of urological healthcare in the region, committed to delivering advanced treatment options to its patients.

Francis Medical, the company behind the Vanquish technology, is dedicated to developing innovative treatments for urological cancers. Their commitment to combining effective cancer treatment with a patient-centered approach forms the cornerstone of their mission. To learn more about their products or the services offered by Orange County Urology Associates, visit Francis Medical and OCUA.

So why is this development significant? The introduction of the Vanquish Water Vapor Ablation treatment signifies not just an innovative medical procedure but reflects a broader trend towards patient-centric, less invasive healthcare technologies. As more practices embrace advancements like these, the future appears promising for those seeking effective management of prostate health.